SCHEMBL6000209

SCHEMBL6000209

CCCC(CCC)c1ccc(COc2ccc(-c3csc(COC(=O)c4ccccc4)n3)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.58
PTPN1 P18031 1/20 0.58
ALOX5 P09917 3/20 0.44
PPARD Q03181 3/20 0.44
PPARA Q07869 2/20 0.44
MAPT P10636 3/20 0.44
RAB9A P51151 4/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
FFAR1 O14842 1/20 0.43
SREBF2 Q12772 1/20 0.43
MMP13 P45452 4/20 0.41
NPC1 O15118 3/20 0.40
PKM P14618 1/20 0.40
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000946 0.87 PTPN2 (0.61) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL6000642 0.87 PTPN2 (0.61) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL6000490 0.83 PTPN2 (0.65) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL5999090 0.83 PTPN2 (0.57) PTPN2PTPN1ALOX5PPARDMAPT
SCHEMBL6000510 0.83 PTPN2 (0.59) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL5998556 0.82 PTPN2 (0.58) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL6000513 0.82 PTPN2 (0.57) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL6001047 0.82 PTPN2 (0.57) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL6001006 0.81 PTPN2 (0.55) PTPN2PTPN1ALOX5PPARDPPARA
SCHEMBL6000919 0.81 PTPN2 (0.57) PTPN2PTPN1ALOX5PPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN2 11/4885PTPN1 2/4885ALOX5 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.